key: cord-0724480-byjzfu58 authors: R, Prathiviraj; P, Chellapandi; Begum, Ajima; Kiran, George Seghal; Selvin, Joseph title: Identification of Genotypic Variants and its Proteomic mutations of Brazilian SARS-CoV-2 Isolates date: 2021-11-03 journal: Virus Res DOI: 10.1016/j.virusres.2021.198618 sha: c9b452d3742085e1e83d0c981205e54aef2aba5a doc_id: 724480 cord_uid: byjzfu58 The second wave of COVID-19 caused by severe acute respiratory syndrome virus (SARS-CoV-2) is rapidly spreading over the world. Mechanisms behind the flee from current antivirals are still unclear due to the continuous occurrence of SARS-CoV-2 genetic variants. Brazil is the world's second-most COVID-19 affected country. In the present study, we identified the genomic and proteomic variants of Brazilian SARS-CoV-2 isolates. We identified 16 different genotypic variants were found among the 27 isolates. The genotypes of three isolates such as Bra/1236/2021 (G15), Bra/MASP2C844R2/2020 (G11), and Bra/RJ-DCVN5/2020 (G9) have a unique mutant in NSP4 (S184N), 2′O-Mutase (R216N), membrane protein (A2V) and Envelope protein (V5A). A mutation in RdRp of SARS-CoV-2, particularly the change of Pro to Leu at 323 resulted in the stabilization of the structure in BRA/CD1739-P4/2020. NSP4, NSP5 protein mutants are more virulent in Genotype 15 and 16. A fast protein folding rate changes the structural stability and leads to escape for current antivirals. Thus, our findings help researchers to develop the best potent antivirals based on the new mutant of Brazilian isolates. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a single strand positive RNA genome that causes coronavirus disease . World Health Organization Several SARS-CoV-2 variants were found to be associated with increased infectivity rate, pathogenesis and displayed a considerably faster transmission through droplets than the wild-type strain (Prathiviraj et al., 2020 , Prathiviraj et al., 2021 . A study realized with the primary human airway epithelial (hACE) cell culture reveals that enhanced transmission rate of SARS-CoV-2 is linked with the effective replication of the viral particle in the upper respiratory tract temperature of 33°C when compared with the lower respiratory tract temperature of 37°C (V'kovski et al., 2021) . RNA-dependent RNA polymerase (RdRp), the enzyme in charge of viral genome replication and transcription (Posthuma et al., 2017) facilitates mutations at various locations in the genome. Errors in the replication and repair systems of the virus lead to the accumulation of additional mutations in the genome (Banoun, 2021; Pachetti et al., 2020) . It must be noted that the mutations described at particular locations do not individually provide fitness to the virus, but a combination of favourable mutations at different locations in the genome, resulting in the improved or diminished functionalities have been classified as clades of mutant viruses harbouring certain moderations (Mercatelli and Giorgi, 2020) . It is important to analyze and interpret the changes at both genotypic and phenotypic levels, as these changes help in understanding the structural changes, pathogenesis, replication and transmission of SARS-CoV-2 (Mousavizadeh and Ghasemi, 2020) in a different environmental niche. Genotyping approach employing single nucleotide polymorphism is essential to identify the genetic changes accumulating during the transmission of SARS-CoV-2 and helps to determine the changes in the property of viral transmission and virulence. Thus, helps to track genotypes associated with topography and epidemiology. The identification of genotypes associated with topographical and contagious groups helps in tracking and monitoring the single nucleotide polymorphism (Yin, 2020) . Genotypic studies help in identifying the phenotypical changes caused due to the replacements of amino acids (Morais et al., 2020) . The protein folding information plays a key role in the therapeutic intervention of many viral diseases (Broglia et al. 2005; Prathiviraj et al., 2021) . The folding process of a protein determines the structural stability and drug binding specificity (Prisilla et al., 2016; Prathiviraj et al., 2016) thus it's most important to identify the folding rate of mutants (Murugan et al., 2019; Prathiviraj et al., 2021) . Analysis of the genotype and phenotype is essential as it aids in understanding the missense, synonymous, and non-synonymous mutations in the virus. In the present study, we identify the number of genotypic variants and proteomic mutants that have recently evolved in Brazilian SARS-CoV-2 isolates. Thus the identified genotypic variants would be useful for developing a new antivirals depending upon the stability of mutants. The complete genomic/nucleotide sequences of Brazilian SARS-CoV-2 isolates and reference Wuhan-Hu-1 SARS-CoV-2 genome were retrieved from the NCBI Virus data repository (https://www.ncbi.nlm.nih.gov/sars-cov-2/). Initial multiple sequence alignment was performed using the PartTree (Katoh and Toh, 2017) algorithm (systematic of large scale alignment) in the MAFFT online server (Katoh et al., 2019) . The aligned file was further imported in MEGA Version X (Kumar et al., 2018) to perform the molecular phylogenomic analysis using the neighbor-joining algorithm (Saitou and Nei, 1987) . Kimura two-parameter (Nishimaki and Sato, 2019) evolutionary substitution model was carried out for estimation of genetic diversity. The phylogenomic tree was computed with 1000 bootstrapping iteration to identify replication among selected isolates. Finally, a huge scale phylogenomic supertree was drawn using the Interactive Tree of Life (iTOL) v4 (Letunic and Bork, 2019) . Nodes of each isolate in the cluster are grouped, colored and classified according to its features. Each open reading frame (ORFs) of nucleotide and protein sequences of retrieved Brazilian isolates were separated, correspond to the genomic and proteomic positions of the reference genome (Wuhan-Hu-1). The alignment of each ORFs was carried out to identify the mutated residues (mismatch region) compared with Wuhan-Hu-1 genome using the BioEdit v7.2 software (Hall, 1999) . Each mutation in the genomic bases of corresponding isolates were cross verified with the Virus pathogen database and analysis resource (ViPR) (Pickett et al., 2012) . Virulence mechanism of identified mutation of each ORFs was predicted using the VICMpred (Saha and Raghava, 2006) and VirulentPred server (Garg and Gupta, 2008) . Identified prediction score of each mutated residue was compared with the reference proteome (Wuhan-Hu-1), to identify its near-native state. Prediction score was computed based on the support vector machine learning algorithm (Rashid et al., 2007) and the final sub-cellular localization score was determined by its functional motifs. The protein folding rate among all the identified mutants was calculated using the FOLD-RATE server (Gromiha et al., 2006) . We performed the phylogenomic discrepancy among the 27 full-length genomic sequences of Brazilian SARS-CoV-2 isolates, so far yet deposited in the NCBI-virus repository (Fig 1) . Out of 27 genomic isolates 19 samples were collected from the year 2020 and 8 from 2021. Genomic features of the selected isolates are represented in Supplementary Table S1 . Phylogenetic analysis demonstrated that the tree was separated into two major clades. First clade shows the origin and replication of Brazilian isolate from the reference Wuhan-Hu-1 genome (red color). Cluster in blue indicates Brazilian isolates of 2020, whereas the second clade represents isolates from 2021 (green). The selected isolates were aligned and compared with Wuhan-Hu-1 genome to identify the mutations. Each ORFs (including non-structural protein from ORF1ab) is pair-wisely aligned separately based on the genomic organization and its position of a reference genome (Table S2 ). Interestingly we found 16 genotypic variants among the 27 Brazilian isolates, based upon the mutation analysis. The first wave of SARS-CoV-2 genome of 2020 has 3-14 mutations, whereas the second wave SARS-CoV-2 genome has 15-20 mutants (Fig 2a; Table S3 ). 3 to 7 mutants were identified in the Nucleocapsid genes with all genotypes (G1 to G16). Numerous mutations were found in PLPro and spike genes of the isolates BRA/CD1739-P4/2020 (11 base change), Bra/1236/2021 (13 base change), and Bra/1061/2021 (12 base change). Comparatively, the identified mutant in the proteomic regions (Fig 2b; Table 1 ) show a huge variation from isolates BRA/CD1739-P4/2020 (11 base changes), BRA/1236/2021, and BRA/1061/2021 (12 base changes) with a higher number of mutations in the spike genes are more virulent. Two to five mutations were identified in the nucleocapsid protein of genotypes G1 to G16. Gene NSP4 (S184N) and membrane protein (A2V) from the isolate BRA/1236/2021 (G15), envelop protein (V5A) from BRA/RJ-DCVN5/2020 (G9), 2'Omutase (R216N) from BRA/MASP2C844R2/2020 (G11) had the single mutation. No mutations were observed in NSP1, NSP8-NSP10 genes of ORFab. The second wave of Brazilian isolates especially spike protein of the genotypes G14-G16 had four times higher mutation than the first wave ( Table 1) . Out of the 27 isolates, eight isolates of 2021 second wave had five times higher mutation than the first wave of 2020 isolates (Fig 2C) . The virulence mechanism of a protein can be resolute by its amino acid composition and the physicochemical properties of substituted amino acids. Our findings show that most of the proteins are involved in the cellular and metabolic process and none are identified from information molecules. The mutant (P323L) identified in RdRp of BRA/CD1739-P4/2020 (G14) transmits its biological function from cellular process to virulence mechanism ( Table 2 ). The protein folding rate is most important to determine the stability of structure and function. It is most imperative to predict the folding rate of protein to identify the various structural changes in the drug binding region. We also predicted the folding mechanism based on its structural classes ( Table 3) . A fast-fold rate was identified in all mutated proteins exactly in β-classes. And slow fold rate was identified in other classes (All-α, α+β:α/β and unknown). Our consequence from evolutionary footprints determines that the mean G+C content was found to be low (<38%) while comparing to the A+T disparity index. It determines that some divergence may occur during the evolutionary transmittance of this genome. Compared with previous research (Prathiviraj et al., 2020) , our findings indicate that some genomic variations may occur at the sequence level, and leads to the origination of a new clade within the isolates in a short time (short-term evolution). Host RNA editing systems, APOBEC and ADAR, responsible for C˃U (accompanied by U˃C mutations by the virus' defense system) and A˃G mutations respectively, account for around 65% of the mutations recorded (Banoun, 2021; Klimczak et al., 2020; Wang et al., 2020) . Deletion of one or a few nucleotides has been reported chiefly in the genes encoding proteins involved in host interaction and the spike protein (Banoun, 2021) . Lin et al., (2021) designated the ~ 500-532 coding region of NSP as a deletion hotspot, and the mutants were found to be linked with reduced virulence (mild disease, low IFN-β in serum) and lower viral load (p14). More deletion variants, primarily of structural protein origin are under scrutiny (Banoun, 2021) . The transition, C>U in the genome has altered the codons to encode amino acids of more hydrophobic nature, thereby producing intense effects on the properties of the protein. This deamination of cytosine-mediated conversion of C to U has helped the SARS-CoV-2 to prompt evolution and adaptation in the host (Maty and Kova, 2020). By analyzing the genomic and proteomic variants of selected isolates we identified both synonymous and non-synonymous substitution mutation evenly occur in all isolates, which leads to drastic changes that may occur in their protein sequences (Chu and Wei, 2019). Several reports have been previously published, that an increased level of mutation in surface glycoprotein may escort a significant role in viral contamination and disease transmission (Yan et al., 2020; Prathiviraj et al., 2021) . As same as the previous report, consequently, our study also correlates the mutational rate is moderately increased in 2020 (Zhao et al., 2004; van Dorp et al., 2020) isolate and drastically increased in 2021 isolates (Pachetti et al., 2020; Callaway, 2020; Vilar and Isom, 2021) for relapsing the antivirals against COVID-19. The spike protein of SARS-CoV-2 is more prone to multiple point mutations It enhanced the rate of transmission and virulence probability due to its increased interaction with the human ACE2 receptor (Zhao et al., 2021) . Accessory protein ORF3a was found to be four distinct types in India, namely, Type 1-4 and it changed the amino sequences in each type. Type 2 of ORF3a was raised from Type 1 by the change of amino acid mutation at the 171 st position. Similarly, the change of amino acids from Asp to Tyr and Ser to Leu by mutation at 463 rd position and 512 th position led to the generation of Type 3 and Type 4, respectively from Type 2. These mutations possibly will affect the pathogenesis of the virus by activating the inflammasomes (Hassan et al., 2020a). Type 2 mutation (S171L) of ORF3a was found in BRA/HIAE-SP03/2020, none other type doesn't exist in Brazilian isolates. Non-synonymous mutations are reported in the envelope protein (E) of the novel coronavirus. We performed a complete genomic and proteomic investigation of the Brazilian SARS-CoV-2 isolate to identify its genotypic variants. From our study, we identified 16 genotypic variants among 27 isolates. The genotype G14-G16 has a high mutation rate in spike protein. The mutations in NSP4 and NSP5 in genotype (G15 and G16) confer lower stability of the protein structures. Our study revealed the mutational effect on the folding rate of assembly and maturation proteins. The slow and fast folding rate of SARS-CoV-2 protein was observed concerning specific mutations. As a result, the current study will help researchers understand the mutation rate among Brazilian isolates and will aid in the discovery of new drugs. 10.1093/oxfordjournals.molbev.a040454. Evolution of SARS-CoV-2: Review of mutations, role of the host immune system No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 One year of SARS-CoV-2: How much has the virus changed Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium Host immune response driving SARS-CoV-2 evolution 2021) D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization 2021) D614G Spike mutation increases SARS CoV-2 susceptibility to neutralization WHO-Weekly epidemiological update on COVID-19, 15 th Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 Genotyping coronavirus SARS-CoV-2: Methods and implications Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity A novel diagnostic test to screen SARS-CoV-2 variants containing E484K and N501Y mutations Moderate mutation rate in the SARS coronavirus genome and its implications SARS-CoV-2 spike D614G change enhances replication and transmission The authors declare that they have no conflict of interest.